Skip to main content

Table 1 Baseline characteristics of study subjects

From: The role of abnormal metabolic conditions on arterial stiffness in healthy subjects with no drug treatment

Variables

Data

Age (years)

48.7 ± 11.8

Male (%)

278 (46.2)

Hypertension (%)

115 (19.1)

Pre-diabetes (%)

187 (31.1)

Diabetes mellitus (%)

30 (5)

 Office systolic BP (mmHg)

129.3 ± 20.6

 Office diastolic BP (mmHg)

79.0 ± 12.7

 Office HR (rate)

81.0 ± 30.9

 Height (cm)

163.1 ± 10.8

Weight (Kg)

65.3 ± 12.5

 waist circumference (cm)

86.6 ± 9.1

 hip circumference (cm)

97.0 ± 6.9

 Total cholesterol (mg/dL)

203.2 ± 37.6

Triglyceride (mg/dL)

135.6 ± 4.7

HDL cholesterol (mg/dL)

52.3 ± 13.3

LDL cholesterol (mg/dL)

123.7 ± 33.7

FBS (mg/dL)

99.6 ± 22.3

HbA1c (%)

5.78 ± 0.71

hsCRP (mg/L)

0.7 (0.03-1.4)

  1. Data are expressed as mean ± standard deviation or number (percent) or median (25 percentile −75 percentile)
  2. BP blood pressure, HR heart rate, HDL high density lipoprotein, LDL low density lipoprotein, FBS fasting blood sugar, HbA1c glycated hemoglocinA1c, hsCRP high sensitivity C reactive protein
Back to article page

Clinical Hypertension

ISSN: 2056-5909

Contact us